Investment styles come in various shapes and sizes. Some focus on growth, others seek regular income through dividends, and others are after stability. The choice depends on many factors, including each investor's goals and preferences. But what if there were a stock that had a decent combined mix of all three of these approaches? That's not just wishful thinking, either: one company to consider along those lines is Amgen (NASDAQ:AMGN), a biotech giant. Image source: The Motley Fool. Amgen has been posting strong financial results. In the second quarter, the company's revenue increased by 10% year over year -- a strong performance for a drugmaker of this size -- to $10.1 billion.
CryptoAlerta — análise de criptomoedas e mercado em tempo real